Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-14

Clinical Trial Update: Effects of Tranexamic Acid on Blood Loss and Transfusion Requirement Following Hip Fracture [NA]

View source ↗

Summary

A clinical trial evaluating whether tranexamic acid reduces blood loss and transfusion requirements after hip fracture.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Rothman Institute Orthopaedics | Conditions: Hip Fracture | NA | Status: UNKNOWN